Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03654716
Title Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute

rhabdoid cancer




Advanced Solid Tumor


ALRN-6924 + Cytarabine


Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Benioff Children's Hospital Recruiting San Francisco California 94158 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Children's Hospital of Philadelphia Recruiting Philadelphia Pennsylvania 19104 United States Details
Texas Children's Hospital, Baylor College of Medicine Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field